Cholesterol Biosynthesis, Transport, and Steroidogenesis – Key Enzymes, Intermediates, and Regulation

Cholesterol Biosynthesis, Transport, and Steroidogenesis

  • Theme: Integration of cholesterol synthesis from acetyl-CoA, intracellular trafficking, storage, and conversion into steroid hormones; regulation by receptors and transcription factors; pharmacologic inhibition (statins, bisphosphonates).

Mevalonate pathway and cholesterol synthesis (Page 1–2)

  • Core starting substrate: Acetyl-CoA.

  • Key enzymes and blocks:

    • HMG-CoA synthase converts acetyl-CoA + acetyl-CoA to HMG-CoA.
    • HMG-CoA reductase converts HMG-CoA to mevalonate; rate-limiting step and target of STATINS.
    • STATINS inhibit HMG-CoA reductase.

  • Mevalonate road-map (intermediates and enzymes):

    • Mevalonate kinase converts mevalonate to mevalonate-5-phosphate.
    • Phosphomevalonate kinase converts mevalonate-5-phosphate to mevalonate-5-pyrophosphate.
    • Mevalonate-5-pyrophosphate decarboxylase yields isopentenyl-PP ($IPP$).
    • Isopentenyl-PP isomerase converts $IPP$ to dimethylallyl-PP ($DMAPP$).
    • Farnesyl-PP synthase condenses $IPP$ with $DMAPP$ to form Farnesyl-PP ($FPP$); subsequent condensations lead to geranyl-PP and then farnesyl-PP.
    • FPP is a branch point for isoprenoids; bisphosphonates act on FPP synthase (listed as BISPHOSPHONATES).

  • Downstream to squalene:

    • Farnesyl-PP synthase and geranylgeranyl-PP synthase contribute to longer isoprenoids and prenylated proteins.
    • Squalene synthase condenses two molecules of FPP to form squalene.
    • Squalene is converted by squalene monooxygenase (squalene epoxidase) to 2,3-oxidosqualene; NADPH is a cofactor in this oxidation step.
    • Oxidosqualene cyclase (lanosterol synthase) converts 2,3-oxidosqualene to lanosterol.

  • From lanosterol to cholesterol:

    • Lanosterol undergoes a series of enzymatic steps (not all detailed here) totaling about 19 reactions to form cholesterol.

  • Other products of the mevalonate pathway (not cholesterol itself):

    • Heme A; Dolichol; Ubiquinone; prenylated proteins.

  • Important notes:

    • Mevalonate pathway intermediates feed into widely different cellular pools (e.g., dolichol for glycoprotein synthesis, ubiquinone in the electron transport chain).
    • Cholesterol can be diverted toward bile salt synthesis in the liver and steroid hormone synthesis in endocrine glands.
    • Biphasic reference: “2 rxns” and other counts appear in the slide sets, indicating steps/reactions in specific subsections; key point is there are numerous enzymatic steps (e.g., the 19-step cholesterol formation path from lanosterol).

  • Intermediates and enzymes listed (from the transcript):

    • Acetoacetyl-CoA, Mevalonic acid (mevalonate), Mevalonate kinase, Mevalonate-5-phosphate, Phosphomevalonate kinase, Mevalonate-5-pyrophosphate, Isopentenyl-PP, Isopentenyl-PP isomerase, Dimethylallyl-PP, Farnesyl-PP synthase, Geranyl-PP, Farnesyl-PP, Geranylgeranyl-PP synthase, Squalene synthase, Squalene, Squalene monooxygenase, 2,3-oxidosqualene, Lanosterol, NADPH, Heme A, Dolichol, Ubiquinone, Prenylated proteins.

  • Note on regulation/regulatory signals: de novo cholesterol synthesis occurs in the endoplasmic reticulum; sterol sensing involves transcriptional regulation (see later sections).

  • Abbreviations in context:

    • ABCA1, SR-B1, NPC1/NPC2, STARD3, ACAT, TSPO, NCEH1/LIPE, perilipins, and lipid droplets relate to cholesterol trafficking, storage, and efflux (described in later sections).

Cholesterol transport, storage, and intracellular regulation (Page 4–5)

  • Cellular trafficking and compartments:
    • LDL receptor pathway: LDL binds receptor, coated vesicle internalization, receptor recycled; endosome/lysosome degrades LDL to free cholesterol.
    • NPC1 and NPC2 proteins mediate cholesterol transport out of lysosomes; cholesterol can be released into the cytosol for storage or membrane synthesis.
    • Endosomal/lysosomal compartment contains acid lipase activity and STARD3 (sterol transfer protein) to facilitate cholesterol movement.
    • De novo cholesterol synthesis largely occurs in the endoplasmic reticulum (ER).
  • Sterol movement and storage:
    • Sterol carrier proteins (e.g., steroidogenic acute regulatory protein STAR, steroid transport proteins) shuttle cholesterol to mitochondria or ER membranes.
    • ACAT (acyl-CoA:cholesterol acyltransferase) esterifies cholesterol to form cholesteryl esters for storage in lipid droplets.
    • Lipid droplets store cholesteryl esters and triglycerides; perilipins regulate lipid droplet dynamics.
  • Efflux and homeostasis:
    • ABCA1 transporter mediates cholesterol efflux to HDL particles; sterol efflux is part of reverse cholesterol transport.
    • SR-B1 mediates selective uptake of cholesteryl esters from HDL into cells.
    • STARD3 and other exchange proteins participate in sterol trafficking within cells.
  • Sterol regulators and signaling:
    • LXR (liver X receptor) is activated by oxysterols and acts as a transcriptional regulator of lipid metabolism genes.
    • SREBP-1c (sterol regulatory element-binding protein 1c) drives expression of fatty acid synthase (FAS) and other lipogenic genes; associated mRNA levels are noted in regulatory schemes.
    • P450scc (CYP11A1) is the cholesterol side-chain cleavage enzyme; STAR (steroidogenic acute regulatory protein) facilitates mitochondrial cholesterol import for steroidogenesis.
    • TAN: CAMP/PKA signaling is involved in cholesterol synthesis and trafficking regulation in some contexts.
  • Key cholesterol-derived products and enzymes listed in the context of cellular cholesterol handling:
    • Cholesterol esters, ACAT, ABCA1, mRNA for Ch synthesis, nuclear regulation, ER localization, and steroidogenic mitochondrial transport.

Steroidogenesis: from cholesterol to steroid hormones (Pages 3, 6–7)

  • Core concept:
    • Cholesterol (27 carbons) is the precursor for all steroid hormones. The major steroidogenic enzymes are compartmentalized: initial steps in mitochondria, later steps in smooth endoplasmic reticulum.
  • Pathway map (core route shown in transcript):
    • Cholesterol ($27$ carbons) → Pregnenolone ($21$ carbons) via cholesterol side-chain cleavage enzyme (CYP11A1) in mitochondria; pregnenolone is the precursor for downstream steroid hormones.
    • Pregnenolone ($21$) → Progesterone ($21$) via 3β-hydroxysteroid dehydrogenase (3β-HSD).
    • Progesterone ($21$) → Testosterone ($19$) via a sequence involving 17α-hydroxylation and further reactions (illustrated as enzymatic conversions on slide).
    • Testosterone ($19$) → Estradiol ($18$) via aromatase (CYP19A1).
  • Alternative/expanded steroid synthesis branches (from Page 6–7):
    • Early steps involve CYP11A1 in mitochondria for pregnenolone production from cholesterol.
    • 17α-hydroxylase (CYP17A1) and 17,20-lyase activities generate androgens and progestins (pathways leading to DHEA, androstenedione, testosterone, etc.).
    • 21-hydroxylase, 11β-hydroxylase, and related enzymes drive the synthesis of glucocorticoids and mineralocorticoids from pregnenolone/progesterone derivatives.
  • Carbon counts and hormone classes (as given in the transcript):
    • Pregnenolone: $21$ carbons.
    • Progesterone: $21$ carbons.
    • Testosterone: $19$ carbons.
    • Estradiol: $18$ carbons.
    • Cholesterol: $27$ carbons.
    • Glucocorticoids (e.g., cortisol) are noted under the “Glucocorticoids” category; mineralocorticoids (e.g., aldosterone) under “Mineralocorticoids.”
  • Enzymes and cellular localization highlighted in steroidogenesis:
    • CYP11A1 (cholesterol side-chain cleavage enzyme) – mitochondrial localization; initiates steroidogenesis by producing pregnenolone.
    • 3β-HSD – converts pregnenolone to progesterone (and related Δ5 to Δ4 conversions).
    • 17α-hydroxylase (CYP17A1) and 17,20-lyase – generate androgens and C21 steroids.
    • 21-hydroxylase – required for synthesis of mineralocorticoids and glucocorticoids.
    • 11β-hydroxylase – completes cortisol synthesis from 11-deoxycortisol; also involved in corticosterone formation.
    • Aldosterone synthase – downstream step in mineralocorticoid production (aldosterone).
    • 17β-HSD – interconverts various active androgens and estrogens.
    • Aromatase – converts androgens to estrogens (e.g., testosterone to estradiol, androstenedione to estrone).
  • Additional regulatory context (linked to steroidogenic enzymes and signaling):
    • Mitochondria are the primary site for the early cholesterol to pregnenolone step; subsequent steps largely occur in smooth endoplasmic reticulum.
    • Transcriptional and signaling regulation involves nuclear receptors and coactivators, aligning with broader cholesterol homeostasis and steroidogenic demand.

Important connections, clinical implications, and practical notes

  • Statins inhibit HMG-CoA reductase to lower cholesterol synthesis, impacting downstream isoprenoid production and sterol homeostasis.
  • Bisphosphonates target FPP synthase, affecting prenylation pathways (farnesyl/geranylgeranyl) and have clinical use in bone disease; this intersects with prenylation steps noted in the mevalonate pathway.
  • LDL receptor–mediated uptake and NPC1/NPC2–dependent lysosomal export are critical for maintaining cellular cholesterol balance; defects here lead to cholesterol storage disorders.
  • ABCA1-mediated cholesterol efflux and SR-B1–mediated HDL uptake are key for reverse cholesterol transport and HDL metabolism.
  • STAR and CYP11A1 (CYP11A1) are essential for delivering cholesterol into mitochondria for steroidogenesis; defects in these steps can affect steroid hormone production.
  • Regulatory networks involving LXR and SREBP-1c coordinate cholesterol, fatty acid, and steroid synthesis, illustrating integration of lipid and hormone metabolism.
  • The pathway complexity includes multiple branches yielding glucocorticoids, mineralocorticoids, and sex steroids, with clinical relevance to adrenal disorders, congenital enzyme deficiencies, and hormone-related diseases.

Notable symbols and terms (quick reference)

  • Enzymes: HMG-CoA reductase, HMG-CoA synthase, mevalonate kinase, phosphomevalonate kinase, mevalonate-5-pyrophosphate decarboxylase, isopentenyl-PP isomerase, dimethylallyl-PP isomerase, Farnesyl-PP synthase, Geranyl-PP synthase, Squalene synthase, Squalene monooxygenase, 2,3-oxidosqualene, Oxidosqualene cyclase (lanosterol synthase), CYP11A1, 3β-HSD, 17α-hydroxylase (CYP17A1), 17,20-lyase, 21-hydroxylase, 11β-hydroxylase, Aldosterone synthase, Aromatase (CYP19A1), 17β-HSD, ACAT, ABCA1, SR-B1, NPC1, NPC2, STARD3, TSPO, NCEH1/LIPE, STAR.
  • Intermediates: Mevalonate, Mevalonate-5-phosphate, Mevalonate-5-pyrophosphate, isopentenyl-PP, dimethylallyl-PP, Farnesyl-PP, Geranyl-PP, Squalene, 2,3-oxidosqualene, Lanosterol, Pregnenolone, Progesterone, Testosterone, Estradiol, Cholesterol, Dolichol, Ubiquinone, Heme A.
  • Cellular localizations: Mitochondria (early step), Endoplasmic reticulum (later steps and transport), Lysosome (cholesterol trafficking).
  • Major regulatory themes: Statins, ABCA1/SR-B1, LXR, SREBP-1c, STAR, CYP enzymes, and lipoprotein transport.